Day: August 9, 2021

Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER™ AAV Capsid and Vectorized Antibody Platform Technologies

Proprietary AAV capsids to power second-generation efforts in Huntington’s disease and ALS, pre-clinical programs in spinal muscular atrophy and diseases...

Nihon Kohden to Elevate Advancements Towards Improved Patient Outcomes with the Acquisition of Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.

Striving to Connect Clinicians with Intelligent Devices and Continuous Data through Predictive Algorithms IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader...

RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders

error: Content is protected !!